Previous Article | Next Article 
Journal of Virology, June 2001, p. 5189-5196, Vol. 75, No. 11
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.11.5189-5196.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
A Herpes Simplex Virus Type 1
34.5 Second-Site Suppressor
Mutant That Exhibits Enhanced Growth in Cultured Glioblastoma Cells
Is Severely Attenuated in Animals
Ian
Mohr,1,*
David
Sternberg,1
Stephen
Ward,2
David
Leib,2
Matthew
Mulvey,1 and
Yakov
Gluzman3,
Department of Microbiology and Kaplan Comprehensive Cancer
Center, New York University School of Medicine, New York, New York
100161; Department of Ophthalmology,
Washington University School of Medicine, St. Louis, Missouri
631102; and Lederle Laboratories,
Wyeth-Ayerst Research, Pearl River, New York
109653
Received 10 October 2000/Accepted 27 February 2001
We describe here the neurovirulence properties of a herpes simplex
virus type 1
34.5 second-site suppressor mutant.
34.5 mutants are
nonneurovirulent in animals and fail to grow in a variety of cultured
cells due to a block at the level of protein synthesis. Extragenic
suppressors with restored capacity to replicate in cells that normally
do not support the growth of the parental
34.5 deletion mutant have
been isolated. Although the suppressor virus reacquires the ability to
grow in nonpermissive cultured cells, it remains severely attenuated in
mice and is indistinguishable from the mutant
34.5 parent virus at
the doses investigated. Repairing the
34.5 mutation in the
suppressor mutant restores neurovirulence to wild-type levels. These
studies illustrate that (i) the protein synthesis and neurovirulence
defects observed in
34.5 mutant viruses can be genetically separated
by an extragenic mutation at another site in the viral chromosome; (ii)
the extragenic suppressor mutation does not affect neurovirulence; and
(iii) the attenuated
34.5 mutant, which replicates poorly in many
cell types, can be modified by genetic selection to generate a
nonpathogenic variant that regains the ability to grow robustly in a
nonpermissive glioblastoma cell line. As this
34.5 second-site
suppressor variant is attenuated and replicates vigorously in
neoplastic cells, it may have potential as a replication-competent,
viral antitumor agent.
*
Corresponding author. Mailing address: Department of
Microbiology, New York University School of Medicine, 550 First Ave., New York, NY 10016. Phone: (212) 263-0415. Fax: (212) 263-8276. E-mail:
ian.mohr{at}med.nyu.edu.

Deceased.
Journal of Virology, June 2001, p. 5189-5196, Vol. 75, No. 11
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.11.5189-5196.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Jin, H., Ma, Y., Prabhakar, B. S., Feng, Z., Valyi-Nagy, T., Yan, Z., Verpooten, D., Zhang, C., Cao, Y., He, B.
(2009). The {gamma}134.5 Protein of Herpes Simplex Virus 1 Is Required To Interfere with Dendritic Cell Maturation during Productive Infection. J. Virol.
83: 4984-4994
[Abstract]
[Full Text]
-
Verpooten, D., Ma, Y., Hou, S., Yan, Z., He, B.
(2009). Control of TANK-binding Kinase 1-mediated Signaling by the {gamma}134.5 Protein of Herpes Simplex Virus 1. J. Biol. Chem.
284: 1097-1105
[Abstract]
[Full Text]
-
Sanchez, R., Mohr, I.
(2007). Inhibition of Cellular 2'-5' Oligoadenylate Synthetase by the Herpes Simplex Virus Type 1 Us11 Protein. J. Virol.
81: 3455-3464
[Abstract]
[Full Text]
-
Mulvey, M., Arias, C., Mohr, I.
(2007). Maintenance of Endoplasmic Reticulum (ER) Homeostasis in Herpes Simplex Virus Type 1-Infected Cells through the Association of a Viral Glycoprotein with PERK, a Cellular ER Stress Sensor. J. Virol.
81: 3377-3390
[Abstract]
[Full Text]
-
Campbell, S. A., Mulvey, M., Mohr, I., Gromeier, M.
(2007). Attenuation of Herpes Simplex Virus Neurovirulence with Picornavirus cis-Acting Genetic Elements. J. Virol.
81: 791-799
[Abstract]
[Full Text]
-
Hu, J. C., Booth, M. J., Tripuraneni, G., Davies, D., Zaidi, S. A.A., Tamburo de Bella, M., Slade, M. J., Marley, S. B., Gordon, M. Y.A., Coffin, R. S., Coombes, R. C., Kamalati, T.
(2006). A Novel HSV-1 Virus, JS1/34.5-/47-, Purges Contaminating Breast Cancer Cells From Bone Marrow.. Clin. Cancer Res.
12: 6853-6862
[Abstract]
[Full Text]
-
Shah, A. C., Price, K. H., Parker, J. N., Samuel, S. L., Meleth, S., Cassady, K. A., Yancey Gillespie, G., Whitley, R. J., Markert, J. M.
(2006). Serial Passage through Human Glioma Xenografts Selects for a {Delta}{gamma}134.5 Herpes Simplex Virus Type 1 Mutant That Exhibits Decreased Neurotoxicity and Prolongs Survival of Mice with Experimental Brain Tumors.. J. Virol.
80: 7308-7315
[Abstract]
[Full Text]
-
Mulvey, M., Camarena, V., Mohr, I.
(2004). Full Resistance of Herpes Simplex Virus Type 1-Infected Primary Human Cells to Alpha Interferon Requires both the Us11 and {gamma}134.5 Gene Products. J. Virol.
78: 10193-10196
[Abstract]
[Full Text]
-
Jing, X., Cerveny, M., Yang, K., He, B.
(2004). Replication of Herpes Simplex Virus 1 Depends on the {gamma}134.5 Functions That Facilitate Virus Response to Interferon and Egress in the Different Stages of Productive Infection. J. Virol.
78: 7653-7666
[Abstract]
[Full Text]
-
Mulvey, M., Poppers, J., Sternberg, D., Mohr, I.
(2003). Regulation of eIF2{alpha} Phosphorylation by Different Functions That Act during Discrete Phases in the Herpes Simplex Virus Type 1 Life Cycle. J. Virol.
77: 10917-10928
[Abstract]
[Full Text]
-
Cheng, G., Yang, K., He, B.
(2003). Dephosphorylation of eIF-2{alpha} Mediated by the {gamma}134.5 Protein of Herpes Simplex Virus Type 1 Is Required for Viral Response to Interferon but Is Not Sufficient for Efficient Viral Replication. J. Virol.
77: 10154-10161
[Abstract]
[Full Text]
-
Ward, S. L., Scheuner, D., Poppers, J., Kaufman, R. J., Mohr, I., Leib, D. A.
(2003). In Vivo Replication of an ICP34.5 Second-Site Suppressor Mutant following Corneal Infection Correlates with In Vitro Regulation of eIF2{alpha} Phosphorylation. J. Virol.
77: 4626-4634
[Abstract]
[Full Text]
-
Cheng, G., Brett, M.-E., He, B.
(2002). Signals That Dictate Nuclear, Nucleolar, and Cytoplasmic Shuttling of the {gamma}134.5 Protein of Herpes Simplex Virus Type 1. J. Virol.
76: 9434-9445
[Abstract]
[Full Text]
-
Child, S. J., Jarrahian, S., Harper, V. M., Geballe, A. P.
(2002). Complementation of Vaccinia Virus Lacking the Double-Stranded RNA-Binding Protein Gene E3L by Human Cytomegalovirus. J. Virol.
76: 4912-4918
[Abstract]
[Full Text]
-
Mao, H., Rosenthal, K. S.
(2002). An N-terminal Arginine-rich Cluster and a Proline-Alanine-Threonine Repeat Region Determine the Cellular Localization of the Herpes Simplex Virus Type 1 ICP34.5 Protein and Its Ligand, Protein Phosphatase 1. J. Biol. Chem.
277: 11423-11431
[Abstract]
[Full Text]
-
Cassady, K. A., Gross, M.
(2002). The Herpes Simplex Virus Type 1 US11 Protein Interacts with Protein Kinase R in Infected Cells and Requires a 30-Amino-Acid Sequence Adjacent to a Kinase Substrate Domain. J. Virol.
76: 2029-2035
[Abstract]
[Full Text]
-
Cassady, K. A., Gross, M., Gillespie, G. Y., Roizman, B.
(2002). Second-Site Mutation Outside of the US10-12 Domain of {Delta}{gamma}134.5 Herpes Simplex Virus 1 Recombinant Blocks the Shutoff of Protein Synthesis Induced by Activated Protein Kinase R and Partially Restores Neurovirulence. J. Virol.
76: 942-949
[Abstract]
[Full Text]
-
Taneja, S., MacGregor, J., Markus, S., Ha, S., Mohr, I.
(2001). Enhanced antitumor efficacy of a herpes simplex virus mutant isolated by genetic selection in cancer cells. Proc. Natl. Acad. Sci. USA
10.1073/pnas.161011798v1
[Abstract]
[Full Text]
-
Taneja, S., MacGregor, J., Markus, S., Ha, S., Mohr, I.
(2001). Enhanced antitumor efficacy of a herpes simplex virus mutant isolated by genetic selection in cancer cells. Proc. Natl. Acad. Sci. USA
98: 8804-8808
[Abstract]
[Full Text]